Mc Carthy Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Mc Carthy Asset Management, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $2,652 - $3,060	42 Added 0.03%	130,363 $8.94 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $89,618 - $109,287	-1,252 Reduced 0.95%	130,321 $9.55 Million
Q4 2023 Feb 02, 2024	BUY	$73.27 - $83.09 $146 - $166	2 Added 0.0%	131,573 $10.7 Million
Q3 2023 Nov 15, 2023	SELL	$73.94 - $80.67 $71,352 - $77,846	-965 Reduced 0.73%	131,571 $9.86 Million
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $19,154 - $21,848	-252 Reduced 0.19%	132,536 $10.2 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $17,703 - $20,170	-229 Reduced 0.17%	132,788 $11 Million
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $1.06 Million - $1.52 Million	-16,967 Reduced 11.31%	133,017 $0
Q3 2022 Oct 28, 2022	SELL	$59.54 - $68.01 $27,805 - $31,760	-467 Reduced 0.31%	149,984 $9.25 Million
Q2 2022 Jul 20, 2022	BUY	$57.72 - $65.01 $115 - $130	2 Added 0.0%	150,451 $9.3 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $115 - $145	2 Added 0.0%	150,449 $8.94 Million
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $91,805 - $104,200	-1,415 Reduced 0.93%	150,447 $10.9 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $165,163 - $178,193	-2,440 Reduced 1.58%	151,862 $10.6 Million
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $604,996 - $661,044	-9,532 Reduced 5.82%	154,302 $10.6 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $516,180 - $588,961	-8,603 Reduced 4.99%	163,834 $10.6 Million
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $9.77 Million - $11.1 Million	172,437 New	172,437 $10 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.